-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Misses Q1 EPS by 4c
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Biohaven Pharma (BHVN), lowers EPS estimates
-
-
-
-
-
-
-
Bairdon Biohaven (BHVN): 'e think case studies from today's presentation answers the major question lingering for BHV-1400'
-
-
-
-
-
-
-
UBS Downgrades Biohaven Pharmaceutical Holding (BHVN) to Neutral
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $15 at Leerink Partners
-
-
-
-
-
-
-
Raymond James on Biohaven Pharmaceutical Holding (BHVN): 'Meaningful Value Remains', 'Sticking with it'
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $26 at UBS
-
416,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

